James Caruso - President and CEO, Cellectar Biosciences, Inc

As of December 28, 2020


James Caruso Net Worth

  • Net worth is estimated to be at least $126.75K
  • Owns at least 81,301 units of Cellectar Biosciences, Inc stock
  • Sold an estimated value of $40.7K in the last 5 years at Cellectar Biosciences, Inc

James Caruso Compensation at Cellectar Biosciences, Inc in 2020

  • Earned a $475,000 salary and a $332 bonus
  • Received a total compensation of $1,016,240

James Caruso Trading

  • Largest purchase of shares was 46,948 units , worth over $99.53K on April 21, 2016
  • Largest sale of shares was 34,000 units , worth over $40.7K on March 14, 2018
  • In total has made about 11 transactions over 5 years
  • Usually trades in November, with the busiest year in 2020 and 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James Caruso Mailing Address

  • Mailing address is C/o Cellectar Biosciences, Inc. 8383 Greenway Blvd Ste 600 Middleton WI 53562 WI

Cellectar Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
James V. Caruso 2020 $475,000 $332,500 $208,740 - $1,016,240
James V. Caruso 2019 $450,500 $213,988 $269,972 - $934,460
Dov Elefant 2020 $324,450 $126,536 $20,874 - $471,860
Dov Elefant 2019 $97,500 $57,788 $157,149 - $312,437
Jarrod Longcor 2020 $353,245 $137,766 $83,496 - $574,507
Jarrod Longcor 2019 $333,250 $94,976 $111,077 - $539,303
Igor Grachev, M.D., Ph.D. 2020 $192,622 - $151,960 $239,494 $584,076
Igor Grachev, M.D., Ph.D. 2019 - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1279704/000110465921065536/tm2114944d1_def14a.htm

Cellectar Biosciences, Inc Insider Trading

  • The most recent transaction was 25,000 units bought on September 14, 2021 by Douglas J Swirsky worth over $26K
  • In the last 7 years, insiders at Cellectar Biosciences, Inc sold an estimated value of $1.22M and bought an estimated value of $3.87M
  • The most active traders are Awm Investment Company Inc,  James V Caruso, President and CEO,  and John Neis, Director
  • Insider trading is most common in June, with the busiest year in 2015

Cellectar Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1